LIFECORE BIOMEDICAL, INC. Other Non-Current Liabilities
LIFECORE BIOMEDICAL, INC. (LFCR) had Other Non-Current Liabilities of $6.75 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $6.75M.
- 2026-03-31: Other Liabilities, Noncurrent $6.73M.
- 2025-12-31: Other Liabilities, Noncurrent $6.70M.
- 2025-09-30: Other Liabilities, Noncurrent $7.96M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $6.75M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $6.73M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $6.70M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $7.96M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $9.74M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $9.81M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $5.15M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $5.11M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $12.06M 10-KT · filed 2026-03-16 | $5.09M 10-K · filed 2024-08-26 |
| 2024-02-25 | $5.05M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $183.00K 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $219.00K 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $174.00K 10-K · filed 2024-08-26 | $3.11M 10-K · filed 2024-03-20 |
| 2023-02-26 | $203.00K 10-K · filed 2024-03-20 | |
| 2022-11-27 | $201.00K 10-K · filed 2024-03-20 | |
| 2022-08-28 | $199.00K 10-K · filed 2024-03-20 | |
| 2022-05-29 | $190.00K 10-K · filed 2024-03-20 | |
| 2022-02-27 | $544.00K 10-K · filed 2024-03-20 | |
| 2021-11-28 | $1.93M 10-K · filed 2024-03-20 | $3.89M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $2.38M 10-K · filed 2024-03-20 | $3.10M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $2.87M 10-K · filed 2024-03-20 | $3.60M 10-K · filed 2021-07-29 |
| 2021-02-28 | $3.03M 10-K · filed 2024-03-20 | $3.76M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $4.02M 10-K · filed 2024-03-20 | $5.36M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $4.14M 10-K · filed 2024-03-20 | $5.00M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $4.55M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $1.46M 10-Q · filed 2020-04-03 | |
| 2019-05-26 | $1.74M 10-K · filed 2020-08-14 | |
| 2015-05-31 | $1.69M 10-K · filed 2015-07-31 | |
| 2014-08-31 | $1.40M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $2.02M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $1.78M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $1.63M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $1.46M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $1.35M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $1.97M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $1.86M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $1.35M 10-Q/A · filed 2013-01-02 | |
| 2012-05-27 | $1.11M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $1.16M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $1.22M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $1.32M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $11.05M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |